Cymabay Therapeutics logo
VerifiedPharmaceutical Manufacturing

Cymabay Therapeutics

We are a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases with high unmet medical need. Seladelpar is a potent, selective, orally active PPARδ agonist in development for the treatment of patients with the autoimmune liver disease, primary biliary cholangitis (PBC). Our pipeline also includes additional investigational products and lead candidates for liver and other chronic diseases.

7-day free trial · no credit card

HeadquartersNewark, United StatesEmployees29(11 to 50)Annual revenue$1B+Websitecymabay.comLinkedIn profileLinkedIn

Verified contacts

39

available on Kipplo

LinkedIn employees

29

11 to 50 range

Open roles

no listings

Distinct roles

35

indexed titles

Tech stack

6

tools in use

Monthly traffic

1.3K

organic / mo

Sign up free to see all 39 verified contacts at Cymabay Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

39 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Cymabay Therapeutics

35 distinct titles indexed · top 10 shown.

  • 2()
  • 2sr clinical trial manager
  • 1, ()
  • 1accounting director
  • 1accounting manager
  • 1associate director director
  • 1chief commercial officer
  • 1cymain company
  • 1desktop engineer
  • 1director
  • +25more titles

Sign up to unlock all 39 contacts at Cymabay Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 39 verified contacts at Cymabay Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Cymabay Therapeutics | Kipplo Discover